Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?

about

Normal variation of bone marrow B-cell precursors according to age - reference ranges for studies in myelodysplastic syndromes in Brazil.

P2860

Q48178188-3E3100E8-1CD8-4132-8603-F63147BE8801

P2860

Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?

Item

http://www.wikidata.org/entity/Q48633334

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?

@en

Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?

@nl

type

Item

label

Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?

@en

Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?

@nl

prefLabel

Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?

@en

Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?

@nl

P1476

Multicenter comparison of CD34 ...... stic syndrome. Is it feasible?

@en

P2093

Celina Benavente

http://www.w3.org/2001/XMLSchema#string

Dolores Subirá

http://www.w3.org/2001/XMLSchema#string

Marta Morado

http://www.w3.org/2001/XMLSchema#string

María Teresa Cedena

http://www.w3.org/2001/XMLSchema#string

Patricia Font

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

The Measurement of Observer Agreement for Categorical Data

Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management

Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes

Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study.

Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data.

Revised international prognostic scoring system for myelodysplastic syndromes.

P304

527-535

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CYTO.B.21538

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sergio Matarraz

J L Díez-Martín

J M Bellón

Ana Maria Pérez-Corral

P577

2017-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28618451

http://www.w3.org/2001/XMLSchema#string

Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?

about

P2860

P2860

Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698